Champions Oncology Q2 EPS $0.03, Sales $11.80M Beat $11.55M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.03 per share. The company reported quarterly sales of $11.80 million which beat the analyst consensus estimate of $11.55 million by 2.16 percent. ThisChampions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.03 per share. The company reported quarterly sales of $11.80 million which beat the analyst consensus estimate of $11.55 million by 2.16 percent. This is a 16.64 percent increase over sales of $10.12 million the same period last year.